EE04612B1 - 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat - Google Patents

5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat

Info

Publication number
EE04612B1
EE04612B1 EEP200100532A EEP200100532A EE04612B1 EE 04612 B1 EE04612 B1 EE 04612B1 EE P200100532 A EEP200100532 A EE P200100532A EE P200100532 A EEP200100532 A EE P200100532A EE 04612 B1 EE04612 B1 EE 04612B1
Authority
EE
Estonia
Prior art keywords
methoxy
methylaminothiocarbonylaminosulfonylphenyl
benzamide
chloro
ethyl
Prior art date
Application number
EEP200100532A
Other languages
English (en)
Estonian (et)
Inventor
Christian Englert Heinrich
Gerlach Uwe
Metzenthin Tobias
Schneider Harald
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200100532A publication Critical patent/EE200100532A/xx
Publication of EE04612B1 publication Critical patent/EE04612B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200100532A 1999-04-16 2000-04-04 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat EE04612B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (de) 1999-04-16 1999-04-16 Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
PCT/EP2000/002984 WO2000063167A1 (en) 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide

Publications (2)

Publication Number Publication Date
EE200100532A EE200100532A (et) 2002-12-16
EE04612B1 true EE04612B1 (et) 2006-04-17

Family

ID=7904803

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100532A EE04612B1 (et) 1999-04-16 2000-04-04 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat

Country Status (33)

Country Link
US (1) US6723751B1 (de)
EP (2) EP1637519B1 (de)
JP (1) JP4662640B2 (de)
KR (1) KR100700302B1 (de)
CN (1) CN1168712C (de)
AR (1) AR023479A1 (de)
AT (2) ATE414059T1 (de)
AU (1) AU773246B2 (de)
BR (1) BR0010658A (de)
CA (1) CA2370388C (de)
CZ (1) CZ302459B6 (de)
DE (3) DE19917233A1 (de)
DK (1) DK1173418T3 (de)
EE (1) EE04612B1 (de)
ES (1) ES2251996T3 (de)
HK (1) HK1046270B (de)
HR (1) HRP20010744B1 (de)
HU (1) HU229082B1 (de)
IL (2) IL145921A0 (de)
ME (1) MEP55708A (de)
MX (1) MXPA01010275A (de)
MY (1) MY122588A (de)
NO (1) NO327798B1 (de)
NZ (1) NZ514788A (de)
PL (1) PL203809B1 (de)
RS (1) RS50916B (de)
RU (1) RU2235089C2 (de)
SI (1) SI1173418T1 (de)
SK (1) SK287175B6 (de)
TR (2) TR200102993T2 (de)
TW (1) TWI276622B (de)
WO (1) WO2000063167A1 (de)
ZA (1) ZA200108400B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1603553T3 (pl) * 2003-03-17 2012-04-30 Japan Tobacco Inc Kompozycje farmaceutyczne inhibitorów CETP
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE146775T1 (de) * 1993-02-23 1997-01-15 Hoechst Ag Substituierte benzolsulfonylharnstoffe und - thioharnstoffe- verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
NZ510424A (en) * 1998-09-10 2003-06-30 Aventis Pharma Gmbh Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers

Also Published As

Publication number Publication date
NO20015014D0 (no) 2001-10-15
IL145921A0 (en) 2002-07-25
EE200100532A (et) 2002-12-16
HK1046270B (zh) 2005-03-11
HUP0200791A3 (en) 2005-04-28
ATE414059T1 (de) 2008-11-15
DE60024431T2 (de) 2006-07-27
IL145921A (en) 2006-07-05
YU72001A (sh) 2004-07-15
DE60040811D1 (de) 2008-12-24
HK1046270A1 (en) 2003-01-03
MXPA01010275A (es) 2003-07-21
NO327798B1 (no) 2009-09-28
SI1173418T1 (sl) 2006-02-28
CN1168712C (zh) 2004-09-29
EP1173418B1 (de) 2005-11-30
DE60024431D1 (en) 2006-01-05
SK14582001A3 (sk) 2002-01-07
TR200102993T2 (tr) 2002-03-21
EP1637519B1 (de) 2008-11-12
SK287175B6 (sk) 2010-02-08
AU4542800A (en) 2000-11-02
JP4662640B2 (ja) 2011-03-30
KR20010109355A (ko) 2001-12-08
RU2235089C2 (ru) 2004-08-27
WO2000063167A1 (en) 2000-10-26
ES2251996T3 (es) 2006-05-16
ATE311364T1 (de) 2005-12-15
DK1173418T3 (da) 2006-04-10
HUP0200791A2 (hu) 2002-07-29
AR023479A1 (es) 2002-09-04
NO20015014L (no) 2001-10-15
US6723751B1 (en) 2004-04-20
MEP55708A (en) 2011-05-10
AU773246B2 (en) 2004-05-20
ZA200108400B (en) 2003-04-30
HU229082B1 (hu) 2013-07-29
CA2370388A1 (en) 2000-10-26
NZ514788A (en) 2003-03-28
CA2370388C (en) 2009-10-13
JP2002542230A (ja) 2002-12-10
MY122588A (en) 2006-04-29
CN1354744A (zh) 2002-06-19
DE19917233A1 (de) 2000-10-19
CZ20013672A3 (cs) 2002-01-16
BR0010658A (pt) 2002-02-19
PL203809B1 (pl) 2009-11-30
CZ302459B6 (cs) 2011-06-01
KR100700302B1 (ko) 2007-03-29
TWI276622B (en) 2007-03-21
EP1173418A1 (de) 2002-01-23
PL351245A1 (en) 2003-04-07
RS50916B (sr) 2010-08-31
EP1637519A1 (de) 2006-03-22
HRP20010744A2 (en) 2003-04-30
TR200501142T2 (tr) 2005-08-22
HRP20010744B1 (hr) 2010-08-31

Similar Documents

Publication Publication Date Title
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
DK1207867T3 (da) Retarderede, orale farmaceutiske indgivelsesformer med tramadol
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE04418B1 (et) Moksifloksatsiini farmatseutiline preparaat
IS2019B (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
PL393385A1 (pl) Sposób modyfikacji i rekrystalizacji pokroju kryształów substancji leczniczej, kryształy mykofenolanu sodu i ich zastosowanie oraz kompozycja farmaceutyczna
EE200300254A (et) Heterotsüklilised ühendid, millel on antibakteriaalne toime, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
EE04839B1 (et) Heterotsükliline benseensulfoonamiidühend, meetodühendi valmistamiseks, ühendi ja selle liitsoola kasutamine ning neid sisaldav terapeutiline kompositsioon
EE04812B1 (et) 2-fenüülpüraan-4-ooni derivaadid, nende valmistamismeetod ja kasutamine, vaheühendite kasutamine jafarmatseutiline kompositsioon
EE04778B1 (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200100532A (et) 5-kloro-2-metoksü-N-[2-(4-metoksü-3-metüülaminotiokarbonüülaminosulfonüülfenüül)etüül]bensamiidi naatriumsoola kristallvormid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline preparaat
EE200100417A (et) (1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200100499A (et) Uued morfoliini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200000024A (et) Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
EE200300548A (et) Uudsed 5-tio-ß-D-ksülopüranosiidi derivaadid, nende valmistamise meetod, neid sisaldavad farmatseutilised kompositsioonid ja nende terapeutiline kasutamine
EE200000369A (et) Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess
NO20021527L (no) Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel
HUP9904011A3 (en) Novel salts of dipeptid derivatives and use of them for producing pharmaceutical compositions
FR2798930B1 (fr) Compose oxazoline-2 et procede de preparation de la trimebutine
EE200200053A (et) Isoretinoiini valmistamise protsess
HUP0100661A3 (en) Salts of paroxetine, process for their preparation and medicaments containing the compounds
ITMI992459A0 (it) Procedimento per la preparazione di marbofloxacina
FR2789990B1 (fr) Procede de preparation de derives d'aminobenzophenones
ITMI991329A0 (it) Procedimento per la preparazione di tetrafluoroalogenobenzeni

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150404